PerkinElmer’s advanced analytics and services solutions for Clinical Development help the world’s leading biopharmaceutical, medical device and diagnostics manufactures discover new therapeutics faster by streamlining clinical operations, transforming risk into safety and enabling actionable decisions that can lead to better health outcomes.


See our exciting new solution for medical monitors, PerkinElmer Signals™ Medical Review which empowers clinical development teams and medical monitors to detect safety signals faster and reduce time to submission by combining innovative medical review workflow with advanced analytics.

The PerkinElmer Risk-Based Monitoring Solution is the most effective way to leverage data-driven insights to optimize site performance while improving patient safety.


Clinical development teams often rely on outside, contracted organizations to provide data or analyses. These sponsors are under enormous regulatory scrutiny. Join Houston Gilbert from Arcus Biosciences, along with experts from PerkinElmer, to learn how Arcus Biosciences, an oncology-focused biopharmaceutical company, tackled the data quality and oversight challenges they faced with their CROs and how they enabled their clinical teams with self-service analytics.

Protect the safety of trials subjects and give medical monitors the ability to increase the quality and speed of their work with this solution.

Medical monitors are overwhelmed by the sheer volume and variety of data they need to sort through to find, investigate, and react to safety signals. To reduce the risk of missing a safety issue and protect trial subjects, monitors need a way to quickly and easily find what they need, without having to hunt through irrelevant data. PerkinElmer Signals Medical Review is purpose-built for medical monitors, enabling them to detect safety signals faster and easier. With the innovative combination of targeted workflow and industry-leading analytics, Signals Medical Review reduces the overall time to submission without compromising safety.

This webcast discusses how central monitors can leverage guided visual analytics to find and act on the right site issues quickly without sifting through mounds of operational and site data.

This webcast discusses how drug safety teams can use dynamic visual analytics to uncover safety issues earlier. All the while, complying with extremely complex and ever-evolving regulatory requirements.

This webcast discusses how medical monitors can leverage guided visual analytics to find and act on the right issues quickly without sifting through mounds of clinical data.


PerkinElmer Informatics, Inc

940 Winter St

Waltham, MA 02451


Phone: 203 925-4602


  • Overcoming Common Challenges Of Clinical Data Review

    Clinical data review is an intrinsic component of clinical development aimed at assuring patient safety, determining drug efficacy, and assessing data quality. It involves rigorous analysis of a broad variety of clinical trial data and often necessitates integration of data from multiple sources in order to extract actionable insights. Here, we look at some of the main challenges of clinical data review and discuss effective strategies to address these, before explaining how our solutions can be deployed to bring urgently needed therapeutics to patients faster.

  • Key To A Faster, More Flexible Clinical Trial Process

    How a single, integrated data analytics and visualization platform, supported by an experienced partner, can help you move your investigational product to market more quickly.

  • Adapting To The Medical Monitor: Driving Tech Adoption In Clinical Analytics

    Reasoning for physician monitors’ reluctance, and what technology needs to offer to convince monitors their work can be more efficient: quickly detecting safety signals and speeding time to submission.

  • Overcoming Clinical Data Aggregation Challenges

    Learn about the challenges for Sponsors and CROs when integrating a vast array of data sources, typical relational database structures and why they don’t work for clinical analytics,  as well as the ideal clinical data aggregation solutions for continuous, automatic data consolidation.

  • The Evolution Of The Modern Medical Monitor

    How to identify, hire, and empower a modern medical monitor to help your next study proceed toward submission more productively, and with greater data integrity, than ever before.

  • Pharma Company Improves Resource Management And Portfolio Planning

    How a $23 billion publicly-held global specialty pharmaceutical company leveraged a software application to strike balance among its clinical studies portfolio, resources, and budget.

  • Exploratory Data Analysis And Safety Assessment In Preclinical And Clinical Studies

    Exploratory data analysis is performed at different levels In the Novartis research and development environment. By implementing a solution that creates a workflow for exploratory clinical safety data analysis they have access to interactive graphical data exploration that provides an efficient, powerful and flexible tool to improve both detection and systematic assessment of safety signals.

  • Which Door To RBM Adoption?

    Overcoming the many known barriers to adopting and implementing an RBM program.

  • To Insource Or Not To Insource: What Is Your Best Clinical Analytics Strategy?

    What to consider when making this important strategic decision.

  • King Arthur’s Excalibur in ICH E6 (r2)

    What is the medical monitor's role in the latest ICH E6 (r2) guidance and how to get them to adopt technology that will help them experience tangible efficiency and quality gains.

  • Are Safety Signals Overlooked In Clinical Trials?

    In this interview, Jennifer Prichard, MD, Medical Monitor at Atlantic Research Group, and Hunter Walker, CTO at Atlantic Research Group (a CRO) will discuss challenges with existing medical monitoring processes, and how new technologies can help improve efficiency.

  • Avoid Missing Critical Safety Signals In Your Trials Video

    Protect the safety of trials subjects and give medical monitors the ability to increase the quality and speed of their work with this solution.

  • Cloud-Based PerkinElmer Signals Medical Review Helps Clinical Development Teams Reduce Risks, Time To Submission

    PerkinElmer, Inc., a global leader committed to innovating for a healthier world, recently announced the launch of PerkinElmer Signals Medical Review.

  • Do THIS To Shorten Your Clinical Trial

    With sponsors facing increasing pressure to reduce drug prices and bring therapies to patients faster, follow these tips to shorten your clinical development process.

  • Unlock Historical Data To Enrich RBM Insights

    The data landscape for clinical operations is complex and comprised of many disparate sources, so a data agnostic solution is essential for full access and visibility into the data. Without an intuitive visual analytics tool, it becomes impossible to navigate data hierarchies and gain meaningful insights into the data.

  • Medical Monitors Fear This The Most

    Insights from medical monitors about the obstacles they face and their impact on the overall study conduct, operational efficiency, and most importantly, subject safety.

  • Transforming Clinical Development

    To enable the completion of clinical trials as safely, efficiently and quickly as possible, PerkinElmer Informatics’ clinical solutions streamline clinical trial data visualization and analysis with real-time access to clinical data in all phases of clinical development.

  • Achieving Clinical Operations Excellence

    Learn how PerkinElmer’s clinical solutions give clinical operations organizations the unprecedented ability to reduce the time, cost and risk of running clinical trials while accelerating the time to market for products across the entire portfolio of clinical candidates.

  • Speeding The Switch To Risk-Based Monitoring

    The adoption of RBM is increasing as companies provide greater management support, staff training and more sophisticated technology systems. Technology platforms that enable continuous monitoring with near real-time intuitive visualizations, analytic dashboards and applications will allow issues to be identified and addressed early, improving study safety and efficiency.

  • The Foundation Of Risk-Based Monitoring Success

    Proponents of RBM projects believe that the investment in this approach will return an overall reduction in monitoring expense by 15 to 20 percent. This paper discusses RBM as a high-value use case that can be enhanced by a robust clinical data aggregation and analytics solution.